# OnCo record nct04534205 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04534205/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04534205", "NCT04534205" ;
  schema:name "A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1"@en ;
  schema:alternateName "AHEAD-MERIT"@en ;
  schema:description "A phase 2/3 trial testing BNT113 in head and neck squamous cell carcinoma, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04534205/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04534205> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2021-01-07" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:drugs <https://onco.cc/drugs/bnt113/> ;
  onco:companies <https://onco.cc/companies/biontech/> .